Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanming Hu

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Journal of Translational Medicine|February 3, 2022
High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?Wanming Hu, Hao Duan, Sheng Zhong, et al.
Clinical Nuclear Medicine|April 17, 2018
Tumor-Induced Osteomalacia Caused by a Parotid Basal Cell Adenoma Detected by 68Ga-DOTANOC PET/CTQiao He, Zeqing Xu, Bing Zhang, et al.
Frontiers in Neuroscience|December 19, 2022
Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningiomaJing Zeng, Lu Sun, Jiaming Huang, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|November 3, 2005
[Effects of eutrophication on distribution and population density of Corbicula fluminea and Bellamya sp. in Chaohu Lake]Daogui Deng, Hongyuan Li, Wanming Hu, et al.
European Journal of Radiology|April 22, 2019
Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurementsHong Chen, Wanming Hu, Haoqiang He, et al.
BMC Medical Genomics|February 25, 2025
m6A regulator-based molecular classification and hub genes associated with immune infiltration characteristics and clinical outcomes in diffuse gliomasJie Lu, Siyu Chen, Wanming Hu, et al.
Dermatologic Therapy|May 16, 2021
Early time to recurrence predicts worse survival in patients with localized or regionally advanced cutaneous melanomaChengcai Liang, Wanming Hu, Jingjing Li, et al.
International Immunopharmacology|July 13, 2024
TIM-3/CD68 double-high expression in Glioma: Prognostic characteristics and potential therapeutic approachesWanming Hu, Depei Li, Yuanzhong Yang, et al.
Computer Methods and Programs in Biomedicine|March 22, 2024
Multi-scale feature fusion for prediction of IDH1 mutations in glioma histopathological imagesXiang Liu, Wanming Hu, Songhui Diao, et al.
Frontiers in Oncology|May 3, 2021
CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in GliomasLiling Liu, Yuanzhong Yang, Hao Duan, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Journal of Translational Medicine|February 3, 2022
High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?Wanming Hu, Hao Duan, Sheng Zhong, et al.
Clinical Nuclear Medicine|April 17, 2018
Tumor-Induced Osteomalacia Caused by a Parotid Basal Cell Adenoma Detected by 68Ga-DOTANOC PET/CTQiao He, Zeqing Xu, Bing Zhang, et al.
Frontiers in Neuroscience|December 19, 2022
Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningiomaJing Zeng, Lu Sun, Jiaming Huang, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|November 3, 2005
[Effects of eutrophication on distribution and population density of Corbicula fluminea and Bellamya sp. in Chaohu Lake]Daogui Deng, Hongyuan Li, Wanming Hu, et al.
European Journal of Radiology|April 22, 2019
Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurementsHong Chen, Wanming Hu, Haoqiang He, et al.
BMC Medical Genomics|February 25, 2025
m6A regulator-based molecular classification and hub genes associated with immune infiltration characteristics and clinical outcomes in diffuse gliomasJie Lu, Siyu Chen, Wanming Hu, et al.
Dermatologic Therapy|May 16, 2021
Early time to recurrence predicts worse survival in patients with localized or regionally advanced cutaneous melanomaChengcai Liang, Wanming Hu, Jingjing Li, et al.
International Immunopharmacology|July 13, 2024
TIM-3/CD68 double-high expression in Glioma: Prognostic characteristics and potential therapeutic approachesWanming Hu, Depei Li, Yuanzhong Yang, et al.
Computer Methods and Programs in Biomedicine|March 22, 2024
Multi-scale feature fusion for prediction of IDH1 mutations in glioma histopathological imagesXiang Liu, Wanming Hu, Songhui Diao, et al.
Frontiers in Oncology|May 3, 2021
CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in GliomasLiling Liu, Yuanzhong Yang, Hao Duan, et al.
Pageof 8